Alprazolam Recall: Xanax XR 3 mg Viatris
Announced 2026-04-15 · FDA
The FDA is recalling Viatris Xanax XR (alprazolam) extended-release tablets, 3 mg, 60-count Rx bottles, distributed nationwide in the US. The recall is due to failed dissolution specifications. Lot# 8177156, Exp Date: 02/28/2027, is affected.
| Brand | Viatris, Inc. |
|---|---|
| Product | Xanax XR, alprazolam, extended-release tablets, 3 mg, 60 Tablets bottles, Rx only, Distributed by: Viatris Specialty LLC, Morgantown, WV 06506, U.S.A, Made in Ireland, NDC 58151-506-91 |
| Reason | Failed Dissolution Specifications |
| Severity | moderate |
| Distribution | US Nationwide. |
| Agency | FDA |
| Recall / campaign no. | Lot# 8177156, Exp Date: 02/28/2027 |
WHAT YOU SHOULD DO
- Check if you have Xanax XR 3 mg tablets from Lot# 8177156 with Exp Date 02/28/2027.
- Do not take or use the recalled tablets.
- Contact your pharmacist or healthcare provider for guidance on disposal, replacement, or refunds.
- If you have questions, contact Viatris or the FDA for instructions.
This is an automatically maintained record of an official recall notice. Details can change; always follow the official notice linked above. See all records in the Recall Database.